Skip to main content

Research

Criteria

Research articles should report on original primary research or novel re-interpretations based on previously published data sets.

Preparing your manuscript

The information below details the section headings that you should include in your manuscript and what information should be within each section.

Please note that your manuscript must include a 'Declarations' section including all of the subheadings (please see below for more information). 

Title page

The title page should:

  • present a concise title that includes, if appropriate, the study design
  • list the full names, institutional addresses and email addresses for all authors
    • if a collaboration group should be listed as an author, please list the Group name as an author. If you would like the names of the individual members of the Group to be searchable through their individual PubMed records, please include this information in the “Acknowledgements” section in accordance with the instructions below
    • Large Language Models (LLMs), such as ChatGPT, do not currently satisfy our authorship criteria. Notably an attribution of authorship carries with it accountability for the work, which cannot be effectively applied to LLMs. Use of an LLM should be properly documented in the Methods section (and if a Methods section is not available, in a suitable alternative part) of the manuscript
  • indicate the corresponding author

Abstract

The Abstract should not exceed 350 words. Please minimize the use of abbreviations and do not cite references in the abstract.

Keywords

Three to ten keywords representing the main content of the article that are not in the title; always add “XX new taxa” to indicate new scientific names are introduced.

Introduction

The Introduction section should explain the background to the study, its aims, a summary of the existing literature, the questions needing to be addressed, and how these were addressed.

Methods 

The methods section should include:

  • Specimen and culture details of material used, with locality, collection, and substrate data, and where voucher materials are deposited.
  • Information on how material was grown in culture (including media, temperature, and period) and examined microscopically (including mountants for measurements)
  • DNA sequence data should be deposited in GenBank and accession numbers included, and alignments in TreeBase.
  • Sources of all phylogenetic and statistical programs should be given.
  • Sources of reagents and suppliers of equipment, with the town and state/country where they are based given in brackets.
  • a clear description of all processes, interventions and comparisons.
  • the type of statistical analysis used, including a power calculation if appropriate

Results

This should include the findings of the study including, if appropriate, results of statistical analysis which must be included either in the text or as tables and figures.

Taxonomy

This section is only required if there are formal taxonomic conclusions, such as the introduction of new scientific names, nomenclatural discussions, and identification keys. 

Note that, except in formal presentations (see below), and throughout the paper scientific names of all ranks are to be placed in italics as in the International Code of Nomenclature for algae, fungi, and plants, with either no author citations, or, if needed for discussion purposes, with the author abbreviation and year of publication.

Entries for each taxon need to be in the form:

  • Scientific name, author(s) [abbreviated as per Index Fungorum)]. For existing names: place of publication (titles in italic [abbreviated as per TL-2for books and BPH-2 for journals], with volume, page number, and year, and any comment on the status of the name. For newly proposed names add “, fam. nov., gen. nov, sp. nov., comb. nov., etc as appropriate.
  • MycoBank/Index Fungorum/Fungal Names registration number for newly proposed taxa (to be obtained AFTER acceptance of the paper).
  • Basionym (for new combinations and replacement names only)
  • Synonyms (where appropriate)
  • Etymology (for new taxa only)
  • Diagnosis (for new taxa only, how the taxon differs from others)
  • Type: with full collection details, where preserved (with fungarium or culture collection acronym and accession numbers), kind of type, and for new typifications of previously named taxa with “hic designatus” followed by a registration number for the typification.
  • Description
  • Habitat/host
  • Distribution
  • Notes
  • Material examined: full collection details, [country, state/province, locality, GPS co-ordinates, substrate/host, date, collector/isolator, and where preserved (with fungarium or culture collection acronym and accession numbers).

Identification keys must be dichotomic, have couplets with indented turnovers, and be numbered with the source of each pair in brackets,

See recent issues for examples of styles.

Discussion

For research articles this section should discuss the implications of the findings in the context of existing research, highlight limitations of the study, and indicate areas where further work is required. For study protocols and methodology manuscripts this section should include a discussion of any practical or operational issues involved in performing the study and any issues not covered in other sections.

Conclusions

This should be short and state clearly the main conclusions and provide an explanation of the importance and relevance of the study to the field.

List of abbreviations

If non-standard abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations can be provided.


Authors are also strongly encouraged to include potential reviewers in the submission to help with the reviewing process.

Declarations

All manuscripts must contain the following sections under the heading 'Declarations':

  • Ethics approval and consent to participate
  • Adherence to national and international regulations
  • Consent for publication
  • Availability of data and material
  • Competing interests
  • Funding
  • Authors' contributions
  • Acknowledgements
  • Authors' information (optional)

Please see below for details on the information to be included in these sections.

If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section. 

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

  • include a statement on ethics approval and consent (even where the need for approval was waived)
  • include the name of the ethics committee that approved the study and the committee’s reference number if appropriate

Studies involving animals must include a statement on ethics approval.

See our editorial policies for more information.

If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.

Adherence to national and international regulations

Manuscripts should confirm adherence to any pertinent national or international legislation or regulations that would apply to the transfer of living biotic materials used in the study between countries. Examples of such regulations are those related to Plant Health and Quarantine, and the Nagaoya Protocol to the Convention on Biological Diversity.

If your manuscript does not involve the use of any living biotic materials originating outside the country where the work was done, please state “Not applicable” in this section.

Consent for publication

If your manuscript contains any individual person’s data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

You can use your institutional consent form or our consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).

See our editorial policies for more information on consent for publication.

If your manuscript does not contain data from any individual person, please state “Not applicable” in this section.

Availability of data and materials

All manuscripts must include an ‘Availability of data and materials’ statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access.

Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):

  • The datasets generated and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]
  • The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
  • All data generated or analysed during this study are included in this published article [and its supplementary information files].
  • The datasets generated and/or analysed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
  • Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
  • The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].
  • Not applicable. If your manuscript does not contain any data, please state 'Not applicable' in this section.

More examples of template data availability statements, which include examples of openly available and restricted access datasets, are available here.

BioMed Central also requires that authors cite any publicly available data on which the conclusions of the paper rely in the manuscript. Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow journal style. Dataset identifiers including DOIs should be expressed as full URLs. For example:


Hao Z, AghaKouchak A, Nakhjiri N, Farahmand A. Global integrated drought monitoring and prediction system (GIDMaPS) data sets. figshare. 2014. http://dx.doi.org/10.6084/m9.figshare.853801

With the corresponding text in the Availability of data and materials statement:

The datasets generated during and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS].[Reference number] 

Competing interests

All financial and non-financial competing interests must be declared in this section.

See our editorial policies for a full explanation of competing interests. If you are unsure whether you or any of your co-authors have a competing interest please contact the editorial office.

Please use the authors initials to refer to each authors' competing interests in this section.

If you do not have any competing interests, please state "The authors declare that they have no competing interests" in this section.

Funding

All sources of funding for the research reported should be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.

Authors' contributions

The individual contributions of authors to the manuscript should be specified in this section. Guidance and criteria for authorship can be found in our editorial policies.

Please use initials to refer to each author's contribution in this section, for example: "FC analyzed and interpreted the patient data regarding the hematological disease and the transplant. RH performed the histological examination of the kidney, and was a major contributor in writing the manuscript. All authors read and approved the final manuscript."

Acknowledgements

Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials. IMA Fungus requires the forename and surname, but does not include academic titles such as Professor or Doctor, or indications of gender such as Mr, Mrs, Miss, or Ms.

Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.

See our editorial policies for a full explanation of acknowledgements and authorship criteria.

If you do not have anyone to acknowledge, please write "Not applicable" in this section.

Group authorship (for manuscripts involving a collaboration group): if you would like the names of the individual members of a collaboration Group to be searchable through their individual PubMed records, please ensure that the title of the collaboration Group is included on the title page and in the submission system and also include collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country information for each author if you wish, but this should be consistent across all authors.

Please note that individual names may not be present in the PubMed record at the time a published article is initially included in PubMed as it takes PubMed additional time to code this information.

Authors' information

This section is optional.

You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.

Footnotes and Endnotes

Footnotes, if considered essential, should be designated within the text using a superscript lowercase letter.

Endnotes are not used in IMA Fungus.

References

Examples of the Basic Springer reference style are shown below. 

See our editorial policies for author guidance on good citation practice.

Web links and URLs: All web links and URLs, including links to the authors' own websites, should be given a reference number and included in the reference list rather than within the text of the manuscript. They should be provided in full, including both the title of the site and the URL, as well as the date the site was accessed, in the following format: The Mouse Tumor Biology Database. http://tumor.informatics.jax.org/mtbwi/index.do. Accessed 20 May 2013. If an author or group of authors can clearly be associated with a web link, such as for weblogs, then they should be included in the reference.

​​​​​​​Example reference style:

Article within a journal

Smith J, Jones M Jr, Houghton L (1999) Future of health insurance. New England Journal of Medicine 965:325-329.

Article by DOI (with page numbers)

Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. Journal of Molecular Medicine 78:74-80. doi:10.1007/s001090000086.

Article by DOI (before issue publication and with page numbers)

Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. Journal of Molecular Medicine. doi:10.1007/s001090000086.

Article in electronic journal by DOI (no paginated version)

Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. Digital Journal of Molecular Medicine. doi:10.1007/s801090000086.

Journal issue with issue editor

Smith J (ed) (1998) Rodent genes. Modern Genomics Journal 14(6):126-233.

Journal issue with no issue editor

Mod Genomics J (1998) Rodent genes. Modern Genomics Journal 14(6):126-233.

Book chapter, or an article within a book

Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York.

Complete book, authored

South J, Blass B (2001) The future of modern genomics. Blackwell, London.

Complete book, edited

Smith J, Brown B (eds) (2001) The demise of modern genomics. Blackwell, London.

Complete book, also showing a translated edition [Either edition may be listed first.]

Adorno TW (1966) Negative Dialektik. Suhrkamp, Frankfurt. English edition: Adorno TW (1973) Negative Dialectics (trans: Ashton EB). Routledge, London.

Chapter in a book in a series without volume titles

Schmidt H (1989) Testing results. In: Hutzinger O (ed) Handbook of environmental chemistry, vol 2E. Springer, Heidelberg, p 111.

Chapter in a book in a series with volume titles

Smith SE (1976) Neuromuscular blocking drugs in man. In: Zaimis E (ed) Neuromuscular junction. Handbook of experimental pharmacology, vol 42. Springer, Heidelberg, pp 593-660.

OnlineFirst chapter in a series (without a volume designation but with a DOI)

Saito, Yukio, and Hyuga, Hiroyuki. (2007) Rate equation approaches to amplification of enantiomeric excess and chiral symmetry breaking. Topics in Current Chemistry. doi:10.1007/128_2006_108.

Proceedings as a book (in a series and subseries)

Zowghi D (1996) A framework for reasoning about requirements in evolution. In: Foo N, Goebel R (eds) PRICAI'96: topics in artificial intelligence. 4th Pacific Rim conference on artificial intelligence, Cairns, August 1996. Lecture notes in computer science (Lecture notes in artificial intelligence), vol 1114. Springer, Heidelberg, p 157.

Article within conference proceedings with an editor (without a publisher)

Aaron M (1999) The future of genomics. In: Williams H (ed) Proceedings of the genomic researchers, Boston, 1999.

Article within conference proceedings without an editor (without a publisher)

Chung S-T, Morris RL (1978) Isolation and characterization of plasmid deoxyribonucleic acid from Streptomyces fradiae. In: Abstracts of the 3rd international symposium on the genetics of industrial microorganisms, University of Wisconsin, Madison, 4-9 June 1978.

Article presented at a conference

Chung S-T, Morris RL (1978) Isolation and characterization of plasmid deoxyribonucleic acid from Streptomyces fradiae. Paper presented at the 3rd international symposium on the genetics of industrial microorganisms, University of Wisconsin, Madison, 4-9 June 1978.

Patent

Norman LO (1998) Lightning rods. US Patent 4,379,752, 9 Sept 1998.

Dissertation

Trent JW (1975) Experimental acute renal failure. Dissertation, University of California.

Book with institutional author

International Anatomical Nomenclature Committee (1966) Nomina anatomica. Excerpta Medica, Amsterdam.

In press article

Major M (2007) Recent developments. In: Jones W (ed) Surgery today. Springer, Dordrecht (in press). 

Online document

Doe J (1999) Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available via DIALOG. http://www.rsc.org/dose/title of subordinate document. Accessed 15 Jan 1999.

Online database

Healthwise Knowledgebase (1998) US Pharmacopeia, Rockville. http://www.healthwise.org. Accessed 21 Sept 1998.

Supplementary material/private homepage

Doe J (2000) Title of supplementary material. http://www.privatehomepage.com. Accessed 22 Feb 2000.

University site

Doe J (1999) Title of preprint. http://www.uni-heidelberg.de/mydata.html. Accessed 25 Dec 1999.

FTP site

Doe J (1999) Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt. Accessed 12 Nov 1999.

Organization site

ISSN International Centre (2006) The ISSN register. http://www.issn.org. Accessed 20 Feb 2007.

Figures, tables and additional files

See General formatting guidelines for information on how to format figures, tables and additional files.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 5.2
    5-year Journal Impact Factor: 5.2
    Source Normalized Impact per Paper (SNIP): 2.022
    SCImago Journal Rank (SJR): 1.376

    Speed 2023
    Submission to first editorial decision (median days): 17
    Submission to acceptance (median days): 194

    Usage 2023
    Downloads: 411,171
    Altmetric mentions: 375